In the first trial of microRNA inhibition to treat heart failure, a novel agent did not reduce left ventricular end-systolic ...
Molecular Circuits of Heart Disease” at Heidelberg University is entering its second funding period. The German Research Foundation (DFG) has approved approximately EUR 17.4 million in funding for the ...
Lecture Will Highlight Expanding Roles of Nuclear Cardiology in the Era of Multimodality Imaging Nuclear cardiology is ...
Following an acute heart attack, pathological remodeling processes occur in the heart. One consequence is so-called left ...
HeartLung.AI will be the only company at ESC Congress 2026 presenting this high number of accepted scientific studies. The achievement reflects the strength of the company’s research program and the ...
NVision raises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next ...
The first consumer experiences powered by true molecular medicine infrastructure are now live at lite.dendrite.com. Take a quiz built from your own genome. Read the seven-chapter story of your biology ...
The ACC, AHA, and HRS have released the 2026 advanced training statement on clinical cardiac electrophysiology.
At the University of Campania 'Luigi Vanvitelli', the Center for Research on Environmental Pollution and Cardiovascular ...
It's common to think that the best diet for heart health is low-fat or fat-free, so you may think you need to avoid cooking ...
I 124 evuzamitide is an investigational PET radiotracer–a radioactive diagnostic imaging agent injected into the body before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results